A clinical trial assessing XH-S004 tablets for the treatment of chronic obstructive pulmonary disease
Latest Information Update: 28 May 2025
At a glance
- Drugs XH S004 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
Most Recent Events
- 28 May 2025 New trial record